William Eggleston1,2, Robert Stoppacher3, Kyle Suen2, Jeanna M Marraffa2,4, Lewis S Nelson5. 1. School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, New York. 2. Department of Emergency Medicine, SUNY Upstate Medical University, Syracuse, New York. 3. Department of Pathology, SUNY Upstate Medical University, Syracuse, New York. 4. Upstate New York Poison Center, Syracuse, New York. 5. Department of Emergency Medicine, Rutgers New Jersey Medical School, Newark, New Jersey.
Abstract
BACKGROUND: Kratom is an herbal supplement containing alkaloids with opioid properties. This review was conducted to determine toxicities associated with kratom use in the United States in order to provide insight into its safety as a dietary supplement. METHODS: We conducted a retrospective review of kratom exposures reported to the National Poison Data System to determine the toxicities associated with kratom use. We also reviewed records from a county medical examiner's office in New York State to identify kratom-associated fatalities. RESULTS: A total of 2312 kratom exposures were reported, with 935 cases involving kratom as the only substance. Kratom most commonly caused agitation (18.6%), tachycardia (16.9%), drowsiness (13.6%), vomiting (11.2%), and confusion (8.1%). Serious effects of seizure (6.1%), withdrawal (6.1%), hallucinations (4.8%), respiratory depression (2.8%), coma (2.3%), and cardiac or respiratory arrest (0.6%) were also reported. Kratom was listed as a cause or contributing factor in the death of four decedents identified by the county medical examiner's office. CONCLUSIONS: Kratom use is increasing and is associated with significant toxicities. Our findings suggest kratom is not reasonably expected to be safe and poses a public health threat due to its availability as an herbal supplement.
BACKGROUND:Kratom is an herbal supplement containing alkaloids with opioid properties. This review was conducted to determine toxicities associated with kratom use in the United States in order to provide insight into its safety as a dietary supplement. METHODS: We conducted a retrospective review of kratom exposures reported to the National Poison Data System to determine the toxicities associated with kratom use. We also reviewed records from a county medical examiner's office in New York State to identify kratom-associated fatalities. RESULTS: A total of 2312 kratom exposures were reported, with 935 cases involving kratom as the only substance. Kratom most commonly caused agitation (18.6%), tachycardia (16.9%), drowsiness (13.6%), vomiting (11.2%), and confusion (8.1%). Serious effects of seizure (6.1%), withdrawal (6.1%), hallucinations (4.8%), respiratory depression (2.8%), coma (2.3%), and cardiac or respiratory arrest (0.6%) were also reported. Kratom was listed as a cause or contributing factor in the death of four decedents identified by the county medical examiner's office. CONCLUSIONS:Kratom use is increasing and is associated with significant toxicities. Our findings suggest kratom is not reasonably expected to be safe and poses a public health threat due to its availability as an herbal supplement.
Authors: Samuel Obeng; Shyam H Kamble; Morgan E Reeves; Luis F Restrepo; Avi Patel; Mira Behnke; Nelson J-Y Chear; Surash Ramanathan; Abhisheak Sharma; Francisco León; Takato Hiranita; Bonnie A Avery; Lance R McMahon; Christopher R McCurdy Journal: J Med Chem Date: 2019-12-27 Impact factor: 7.446
Authors: Yuchen Zhou; Steven Ramsey; Davide Provasi; Amal El Daibani; Kevin Appourchaux; Soumen Chakraborty; Abhijeet Kapoor; Tao Che; Susruta Majumdar; Marta Filizola Journal: Biochemistry Date: 2020-12-04 Impact factor: 3.162
Authors: Alessandro E Vento; Simone de Persis; Sergio De Filippis; Fabrizio Schifano; Flavia Napoletano; John M Corkery; Georgios D Kotzalidis Journal: Front Psychiatry Date: 2021-03-31 Impact factor: 4.157
Authors: Anna M Gutridge; Soumen Chakraborty; Balazs R Varga; Elizabeth S Rhoda; Alexander R French; Arryn T Blaine; Quinten H Royer; Haoyue Cui; Jinling Yuan; Robert J Cassell; Márk Szabó; Susruta Majumdar; Richard M van Rijn Journal: Front Pharmacol Date: 2021-11-03 Impact factor: 5.988